- Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
- Predictive Oncology to Participate in Upcoming Investor Conferences
- Predictive Oncology to Participate in Upcoming San Francisco Conferences
- Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
- Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
- Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
- Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.30 |
---|---|
High | 1.41 |
Low | 1.15 |
Bid | 0.5055 |
Offer | 1.84 |
Previous close | 1.15 |
Average volume | 31.55k |
---|---|
Shares outstanding | 4.06m |
Free float | 3.92m |
P/E (TTM) | -- |
Market cap | 4.67m USD |
EPS (TTM) | -3.48 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 20:59 BST.
More ▼